Skip to main content

Table 1 Characteristics of post-mortem human brain samples

From: The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer’s disease

Brain Region: Hippocampus (paraffin-embedded)

Braak Stage

Number of Subjects

Age at Deatha

Genderb

APOE4 Statusc

CERAD Scored

Diagnosise

I

6

79 ± 6.8

M (1) F (5)

+ (1), − (2)

O(2), A(2), B(2)

NDCNTRL

II

6

85.7 ± 1.8

M (1) F (5)

+ (2), − (4)

A(1), B(3), C(2)

NDCNTRL

III

6

82 ± 5.8

M (5) F (1)

+ (3), − (2)

A(1), B(2), C(3)

NDCNTRL

IV

7

92.3 ± 3.3

M (1) F (6)

+ (2), − (5)

C

NDCNTRL (2), AD(5)

V

4

82.3 ± 10.1

M (0) F (4)

+ (3), − (1)

C

AD

VI

6

86 ± 6.8

M (0) F (6)

+ (4), − (2)

C

AD

Brain Region: Cortex (paraffin-embedded)

Braak Stage

Number of Subjects

Age at Death

Gender

APOE4 Status

CERAD Score

Diagnosis

I

4

82.5 ± 9.3

M (2) F (2)

+ (0), − (4)

A(1), B(2), C(1)

NDCNTRL

II

3

85.3 ± 0.5

M (1) F (2)

+ (1), − (2)

A(1), B(3), C(2)

NDCNTRL

III

4

87 ± 3.7

M (3) F (1)

+ (2), − (2)

A(1), B(2), C(3)

NDCNTRL

IV

6

89.3 ± 5.4

M (2) F (4)

+ (3), − (3)

B(2), C(4)

NDCNTRL (2), AD (4)

V

3

84.3 ± 13.2

M (0) F (3)

+ (2), − (1)

C

AD

VI

5

89.2 ± 3.4

M (0) F (5)

+ (4), − (1)

C

AD

Brain Region: Cortex (frozen)

Braak Stage

Number of Subjects

Age at Death

Gender

APOE4 Status

CERAD Score

Diagnosis

I – II

4

88.7 ± 7.9

M (0) F (4)

+ (0), − (2)

O(1), A(1), B(1), C(1)

NDCNTRL

III – IV

5

91.4 ± 2.9

M (1) F (4)

+ (1), − (2)

O(1), B(2), C(2)

NDCNTRL (3), AD (2)

V – VI

5

75.2 ± 8.1

M (2) F (3)

+ (2), −(2)

B(1), C(4)

AD

  1. a Age at death is reported as mean ± standard deviation
  2. b M Male, F Female
  3. c APOE4 Status +: APOE3/4 or APOE4/4, −:APOE3/3, APOE3/2, APOE2/2. APOE4 status were not available for some subjects
  4. d CERAD Consortium to Establish a Registry for Alzheimer’s Disease
  5. e NDCNTRL Non-demented control, AD Alzheimer’s disease patient